CPA Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,809
Closed -$302K 98
2026
Q1
$302K Hold
4,809
0.1% 77
2025
Q4
$459K Buy
4,809
+4
+0.1% +$392 0.16% 62
2025
Q3
$469K Buy
4,805
+8
+0.2% +$828 0.18% 63
2025
Q2
$515K Hold
4,797
0.22% 57
2025
Q1
$484K Hold
4,797
0.21% 57
2024
Q4
$428K Sell
4,797
-171
-3% -$15.1K 0.2% 57
2024
Q3
$416K Hold
4,968
0.2% 57
2024
Q2
$383K Hold
4,968
0.2% 58
2024
Q1
$340K Hold
4,968
0.19% 56
2023
Q4
$287K Sell
4,968
-1,092
-18% -$58.3K 0.17% 65
2023
Q3
$320K Hold
6,060
0.22% 56
2023
Q2
$328K Hold
6,060
0.24% 54
2023
Q1
$303K Buy
6,060
+800
+15% +$37.7K 0.23% 53
2022
Q4
$243K Buy
+5,260
New +$228K 0.19% 59

Other funds holding BSX

CPA Asset Management's BSX Position: Q2 2026 in Review

CPA Asset Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,809 shares — an estimated $302K sold.

CPA Asset Management first reported a position in BSX in Q4 2022 and held it in 14 quarters. The position peaked at $515K in Q2 2025. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • CPA Asset Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • CPA Asset Management sold 4,809 Boston Scientific shares in Q2 2026, an estimated $302K.
  • CPA Asset Management first reported a position in Boston Scientific in Q4 2022 and held it in 14 quarters.
  • CPA Asset Management's Boston Scientific position peaked at $515K in Q2 2025.
  • 534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on CPA Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.